Clinical Trial Update: Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating topical 20% beta-caryophyllene alone and with 0.025% capsaicin for knee pain due to osteoarthritis; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee
• Pain

Drugs mentioned

• Beta-caryophyllene (topical 20%) (beta-caryophyllene)
• Capsaicin (topical 0.025%) (capsaicin)

Snippet

Sponsor: Panag Pharma Inc. | Conditions: Pain | Phase 2 | Status: COMPLETED